Aging Well, Sleeping Efficiently

延年益寿,高效睡眠

基本信息

项目摘要

DESCRIPTION (provided by applicant): This application is a revised version (A1) of a competing renewal for years 06 through 10 of program project grant POI AG020677 ("Aging Well, Sleeping Efficiently"). Insomnia in older adults is a widely prevalent health condition that is associated with significant distress, functional impairment, increased utilization of healthcare, and high financial costs. The aim of the program is to identify novel physiological, electrophysiological, genetic and functional neuroanatomical correlates of insomnia in older adults. All projects will use treatment with Cognitive Behavioral Treatment of Insomnia (CBTI), as an "intervention challenge" to determine how changes in insomnia symptoms affect these correlates of insomnia. The program has four inter-related projects and three cores examining a group of 120 Older Adults with Insomnia (OAI) all receiving CBTI, as well as a demographically balanced group of 100 good sleepers (GS). All participants will be 60y+; both genders will be studied. Projects 1-3 will each examine a subset of the participants. Advertising for participant recruitment will be provided by Core A {Administration - Monk). All participants will be recruited, telephone pre-screened, consented for screening and screened using Core B (Clinical core - Buysse/Germain) resources, and then assigned to one of three different projects using procedures provided by Core C {Data Management and Statistics - Mazumdar/Hall). All participants will contribute to Project 4 {Genetics - Nimgaonl<at). Core B will also be responsible for delivering the CBTI and collecting clinical variables. Core A will provide general administration; Core C will handle data analysis and statistics. Project 1 {Circadian/homeostatic - Monk/Buysse) will involve a laboratory evaluation of circadian rhythms and sleep homeostasis using a sleep deprivation challenge; Project 2 {Hyperarousal - Hall) will use a series of laboratory challenges to evaluate the dynamic properties of psycho-physiological arousal; Project 3 {PET imaging - Nofzinger) will involve PET imaging during NREM sleep and wakefulness. Project 4 {Genetics-Nimgaonkar) will examine polymorphisms and functional properties of the Per3 gene, examining correlations between these polymorphisms and behavioral and physiologic variables. All four of the component projects essentially have two major aims: 1) to investigate baseline correlates of insomnia in older adults within their particular domain of interest; and 2) to determine whether these correlates also relate to the level of success of a non-pharmacological treatment for insomnia (CBTI). This Program Project will significantly advance our understanding of insomnia and its treatment in older adults.
描述(由申请人提供):本申请是项目资助POI AG020677(“老化良好,睡眠有效”)第06年至第10年竞争性续期的修订版本(A1)。老年人失眠是一种普遍存在的健康状况,与严重的痛苦、功能损害、医疗保健利用率增加和高财务成本有关。该项目的目的是确定老年人失眠的新的生理、电生理、遗传和功能神经解剖学相关性。所有项目都将使用认知行为治疗失眠(CBTI),作为一项“干预挑战”,以确定失眠症状的变化如何影响失眠的相关因素。该项目有四个相互关联的项目和三个核心,研究了120名接受CBTI治疗的失眠症老年人(OAI),以及100名人口统计学上平衡的睡眠良好者(GS)。所有参与者为60岁以上;男女都将被研究。项目1-3将分别检查参与者的一个子集。招募参与者的广告将由Core A (Administration - Monk)提供。所有参与者将被招募,电话预筛选,同意筛选并使用核心B(临床核心- Buysse/Germain)资源进行筛选,然后使用核心C(数据管理和统计- Mazumdar/Hall)提供的程序分配到三个不同的项目之一。所有参与者都将为项目4 {Genetics - Nimgaonl<at]做出贡献。核心B也将负责提供CBTI和收集临床变量。核心A将提供一般管理;Core C将处理数据分析和统计。项目1{昼夜节律/体内平衡- Monk/Buysse)将涉及使用睡眠剥夺挑战对昼夜节律和睡眠体内平衡进行实验室评估;项目2{高唤醒-霍尔)将使用一系列实验室挑战来评估心理生理唤醒的动态特性;项目3 {PET成像- Nofzinger)将涉及非快速眼动睡眠和清醒期间的PET成像。项目4{遗传学- nimgaonkar)将检查Per3基因的多态性和功能特性,检查这些多态性与行为和生理变量之间的关系。所有四个组成部分项目基本上有两个主要目的:1)在他们感兴趣的特定领域内调查老年人失眠的基线相关性;2)确定这些相关性是否也与非药物治疗失眠(CBTI)的成功程度有关。该项目将显著提高我们对老年人失眠症及其治疗的认识。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Daniel J. Buysse其他文献

A randomized trial of adapted versus standard versions of the Transdiagnostic Intervention for Sleep and Circadian Dysfunction implemented via facilitation and delivered by community mental health providers: improving the “fit” of psychological treatments by adapting to context
  • DOI:
    10.1186/s13012-025-01440-9
  • 发表时间:
    2025-07-09
  • 期刊:
  • 影响因子:
    13.400
  • 作者:
    Allison G. Harvey;Emma R. Agnew;Rafael Esteva Hache;Julia M. Spencer;Marlen Diaz;Estephania Ovalle Patino;Anne Milner;Lu Dong;Amy M. Kilbourne;Daniel J. Buysse;Catherine A. Callaway;Laurel D. Sarfan
  • 通讯作者:
    Laurel D. Sarfan
Correction to: Subjective and neural reactivity during savoring and rumination
  • DOI:
    10.3758/s13415-023-01145-w
  • 发表时间:
    2024-02-20
  • 期刊:
  • 影响因子:
    2.700
  • 作者:
    Benjamin O. Brandeis;Greg J. Siegle;Peter Franzen;Adriane Soehner;Brant Hasler;Dana McMakin;Kym Young;Daniel J. Buysse
  • 通讯作者:
    Daniel J. Buysse
Alpha-2-adrenergic agonists reduce resting energy expenditure in humans during external cooling
α-2-肾上腺素能激动剂可减少外部冷却期间人体的静息能量消耗
  • DOI:
    10.1080/23328940.2024.2339781
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Clifton W. Callaway;Katharyn L Flickinger;Alexandra Weissman;Francis X. Guyette;Ryann DeMaio;Andrea Jonsson;Victor Wu;Jenna L. Monteleone;Peter Prescott;Jonathan Birabaharan;Daniel J. Buysse;P. Empey;Thomas D. Nolin;Raymond E. West
  • 通讯作者:
    Raymond E. West
総合病院精神科におけるアルコール健康障害への取り組みと、「減酒外来」について
综合医院精神科和“戒酒门诊”致力于治疗酒精相关疾病
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ryuji Furihata;Yukiko Tateyama;Yukako Nakagami;Toshiki Akahoshi;Osamu Itani;Yoshitaka Kaneita;Daniel J. Buysse;角南隆史
  • 通讯作者:
    角南隆史
Sleep intervention and glycemic control in gestational diabetes mellitus: a feasibility study
妊娠期糖尿病中的睡眠干预与血糖控制:一项可行性研究
  • DOI:
    10.1016/j.ajogmf.2022.100836
  • 发表时间:
    2023-02-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Roxanna M. Twedt;Daniel J. Buysse;Peter L. Franzen;Megan E. Hamm;Francesca L. Facco
  • 通讯作者:
    Francesca L. Facco

Daniel J. Buysse的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Daniel J. Buysse', 18)}}的其他基金

1/2 Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia Phenotypes Based on Objective Sleep Duration: A Sequential Cohort/Randomized Controlled Trial
基于客观睡眠持续时间的 1/2 认知行为疗法和曲唑酮对失眠表型睡眠和血压的影响:序贯队列/随机对照试验
  • 批准号:
    10590135
  • 财政年份:
    2023
  • 资助金额:
    $ 186.89万
  • 项目类别:
Pragmatic trial of behavioral interventions for insomnia in hypertensive patients
高血压患者失眠行为干预的实用性试验
  • 批准号:
    9125875
  • 财政年份:
    2014
  • 资助金额:
    $ 186.89万
  • 项目类别:
Pragmatic trial of behavioral interventions for insomnia in hypertensive patients
高血压患者失眠行为干预的实用性试验
  • 批准号:
    8792640
  • 财政年份:
    2014
  • 资助金额:
    $ 186.89万
  • 项目类别:
Pragmatic trial of behavioral interventions for insomnia in hypertensive patients
高血压患者失眠行为干预的实用性试验
  • 批准号:
    9325558
  • 财政年份:
    2014
  • 资助金额:
    $ 186.89万
  • 项目类别:
Dimensional Sleep Disturbance in Relation to Positive/Negative Affect Systems
与积极/消极情感系统相关的维度睡眠障碍
  • 批准号:
    8765960
  • 财政年份:
    2014
  • 资助金额:
    $ 186.89万
  • 项目类别:
2/3-Improving Depression Outcome by Adding CBT for Insomnia to Antidepressants
2/3-通过在抗抑郁药中添加治疗失眠的 CBT 来改善抑郁症的结果
  • 批准号:
    8255615
  • 财政年份:
    2008
  • 资助金额:
    $ 186.89万
  • 项目类别:
2/3-Improving Depression Outcome by Adding CBT for Insomnia to Antidepressants
2/3-通过在抗抑郁药中添加治疗失眠的 CBT 来改善抑郁症的结果
  • 批准号:
    7817029
  • 财政年份:
    2008
  • 资助金额:
    $ 186.89万
  • 项目类别:
2/3-Improving Depression Outcome by Adding CBT for Insomnia to Antidepressants
2/3-通过在抗抑郁药中添加治疗失眠的 CBT 来改善抑郁症的结果
  • 批准号:
    8071232
  • 财政年份:
    2008
  • 资助金额:
    $ 186.89万
  • 项目类别:
2/3-Improving Depression Outcome by Adding CBT for Insomnia to Antidepressants
2/3-通过在抗抑郁药中添加治疗失眠的 CBT 来改善抑郁症的结果
  • 批准号:
    7626661
  • 财政年份:
    2008
  • 资助金额:
    $ 186.89万
  • 项目类别:
Translational Research Training in Sleep Medicine
睡眠医学转化研究培训
  • 批准号:
    8213306
  • 财政年份:
    2007
  • 资助金额:
    $ 186.89万
  • 项目类别:

相似国自然基金

小型类人猿合唱节奏的功能假说——宣 示社会关系(Social bond advertising) ——验证研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目

相似海外基金

SaTC: CORE: Medium: Increasing user autonomy and advertiser and platform responsibility in online advertising
SaTC:核心:中:增加在线广告中的用户自主权以及广告商和平台责任
  • 批准号:
    2318290
  • 财政年份:
    2024
  • 资助金额:
    $ 186.89万
  • 项目类别:
    Continuing Grant
Marketing meaninglessness: critical anthropology of transnational advertising agencies
营销无意义:跨国广告公司的批判人类学
  • 批准号:
    2724869
  • 财政年份:
    2024
  • 资助金额:
    $ 186.89万
  • 项目类别:
    Studentship
Innovation in Manufacturing to benefit the Marketing & Advertising Industry
制造创新有利于营销
  • 批准号:
    10064566
  • 财政年份:
    2023
  • 资助金额:
    $ 186.89万
  • 项目类别:
    Collaborative R&D
Collaborative Research: SaTC: CORE: Medium: Understanding and Combatting Impersonation Attacks and Data Leakage in Online Advertising
协作研究:SaTC:核心:媒介:理解和打击在线广告中的冒充攻击和数据泄露
  • 批准号:
    2247516
  • 财政年份:
    2023
  • 资助金额:
    $ 186.89万
  • 项目类别:
    Continuing Grant
A Dynamic Analysis of Advertising Interactive Techniques to Gain the Consumer Engagement
获得消费者参与的广告互动技术的动态分析
  • 批准号:
    23K01642
  • 财政年份:
    2023
  • 资助金额:
    $ 186.89万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Impact of Programmatic Advertising on Market Competition
程序化广告对市场竞争的影响
  • 批准号:
    23K18786
  • 财政年份:
    2023
  • 资助金额:
    $ 186.89万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Enabling profitable digital advertising for British SMEs with AI-powered multichannel ads brokerage service
通过人工智能驱动的多渠道广告经纪服务,为英国中小企业实现盈利的数字广告
  • 批准号:
    10070962
  • 财政年份:
    2023
  • 资助金额:
    $ 186.89万
  • 项目类别:
    Collaborative R&D
Cross-Platform Advertising Accountability
跨平台广告责任
  • 批准号:
    10071299
  • 财政年份:
    2023
  • 资助金额:
    $ 186.89万
  • 项目类别:
    Collaborative R&D
Improving the accountability of dark advertising on digital platforms
提高数字平台上暗广告的问责制
  • 批准号:
    IE230100647
  • 财政年份:
    2023
  • 资助金额:
    $ 186.89万
  • 项目类别:
    Early Career Industry Fellowships
An AI/ML-powered insight and improvement tool to help bricks and mortar Mission-Led Business (MLBs) to improve advertising, marketing and business performance
一款由 AI/ML 驱动的洞察和改进工具,可帮助实体任务主导型企业 (MLB) 改善广告、营销和业务绩效
  • 批准号:
    10067255
  • 财政年份:
    2023
  • 资助金额:
    $ 186.89万
  • 项目类别:
    Collaborative R&D
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了